These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 12820340

  • 1. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B, Caffier H, Sütterlin MW, Dietl J.
    Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM.
    Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
    Tauchert S, di Liberto A, Cordes T, Thill M, Salehin D, Friedrich M.
    Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY, Wu YY, Janckila AJ.
    Clin Chim Acta; 2010 Nov 11; 411(21-22):1553-64. PubMed ID: 20599857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer.
    Wada N, Ishii S, Ikeda T, Enomoto K, Kitajima M.
    Anticancer Res; 1999 Nov 11; 19(5C):4515-21. PubMed ID: 10650803
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients.
    Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K, Böttcher HD.
    Anticancer Res; 2003 Nov 11; 23(3C):2783-8. PubMed ID: 12926113
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z, Konieczna M, Wańkowicz Z.
    Pol Merkur Lekarski; 2004 Aug 11; 17(98):138-41. PubMed ID: 15603322
    [Abstract] [Full Text] [Related]

  • 17. Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.
    Chao TY, Yu JC, Ku CH, Chen MM, Lee SH, Janckila AJ, Yam LT.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):544-50. PubMed ID: 15701839
    [Abstract] [Full Text] [Related]

  • 18. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer.
    Salminen E, Ala-Houhala M, Korpela J, Varpula M, Tiitinen SL, Halleen JM, Väänänen HK.
    Acta Oncol; 2005 Jan 15; 44(7):742-7. PubMed ID: 16227166
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate.
    Martinetti A, Seregni E, Ripamonti C, Ferrari L, De Conno F, Miceli R, Pallotti F, Coliva A, Biancolini D, Bombardieri E.
    Int J Biol Markers; 2002 Jan 15; 17(4):253-8. PubMed ID: 12521129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.